Clinical trial
The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy - a Prospective Randomized Double Blind Placebo-control Study
NCT02637986 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy - a Prospective Randomized Double Blind Placebo-control Study
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- November 7, 2022
- Completion date
- November 7, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
urinary tract infections (utis)